- Home
- LYB vs NBIX Comparison
LYB vs NBIX Comparison
Compare LYB & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LYB | NBIX |
|---|---|---|
| Founded | 1955 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3B | 13.9B |
| IPO Year | 2010 | 1996 |
Fundamental Metrics
Financial Performance| Metric | LYB | NBIX |
|---|---|---|
| Price | $75.40 | $130.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 22 |
| Target Price | $64.73 | ★ $175.27 |
| AVG Volume (30 Days) | ★ 8.2M | 901.1K |
| Earning Date | 04-24-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | N/A | ★ 41.95 |
| EPS | N/A | ★ 4.67 |
| Revenue | ★ $30,153,000,000.00 | $161,626,000.00 |
| Revenue This Year | N/A | $22.85 |
| Revenue Next Year | $0.70 | $9.99 |
| P/E Ratio | ★ N/A | $27.99 |
| Revenue Growth | N/A | ★ 977.51 |
| 52 Week Low | $41.58 | $84.23 |
| 52 Week High | $76.10 | $160.18 |
Technical Indicators
Market Signals| Indicator | LYB | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 76.05 | 48.44 |
| Support Level | $43.01 | $128.03 |
| Resistance Level | N/A | $136.74 |
| Average True Range (ATR) | 3.19 | 2.86 |
| MACD | 0.90 | 0.33 |
| Stochastic Oscillator | 96.26 | 47.92 |
Price Performance
Historical ComparisonAbout LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.